Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 49 No. 1
PSYCHOPHARMACOLOGY BULLETIN

VOL 49 No. 1

Articles in This Issue

ORIGINAL RESEARCH

Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial

Murat Altinay, Harish Karne, Amit Anand
Introduction and Background Patients with depression who fail to respond to at least two antidepressants in their current episode are considered to have Treatment Resistant Depression (TRD). ECT is an effective treatment of TRD but...
Pages 8-16 Read Article
EVIDENCE BASED MEDICINE

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Camilla Callegari, Marta Ielmini, Ivano Caselli, Giulia Lucca, Celeste Isella, Marcello Diurni, Fabiana Pettenon, Nicola Poloni
Background The impact of menopause is a consequence of social, physical and mental changes; hormonal changes play an important role in inducing an increased risk of developing depressive symptoms. It is essential to treat mood...
Pages 28-43 Read Article
EVIDENCE BASED MEDICINE

The Impact of Completing Medication Reconciliation and Depression Treatment History in an Outpatient Depression Clinic

Sarah J. Choi, Roberta Storey, Sagar V. Parikh, Jolene R. Bostwick
Objectives To enhance depression care by improving medication information available prior to initial patient consultations. Experimental Design and Sample Single-center, with intervention delivered to all new patient referrals at a tertiary care depression clinic. Trained...
Pages 44-55 Read Article
GENERAL PSYCHIATRY

Exercise as a Treatment for Schizophrenia: A Review

Steven J. Girdler, Jamie E. Confino, Mary E. Woesner
Schizophrenia is a mental disorder that is characterized by progressive cognitive impairment in areas of attention, working memory, and executive functioning. Although no clear etiology of schizophrenia has been discovered, many factors have been identified...
Pages 56-69 Read Article
GENERAL PSYCHIATRY

Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice

Antonio Siniscalchi, Giovambattista De Sarro, Roberta Pacifici, Ermanno Pisani, Sandro Sanguigni, Luca Gallelli
Alteplase is the main pharmacological treatment available for intravenous thrombolysis in patients with acute ischemic stroke. Endovascular treatment alone or add-on to intravenous thrombolysis is a valid approach in acute ischemic stroke with cerebral large...
Pages 70-79 Read Article
COMPLICATED CASE HISTORIES

Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report

Gangaparameswari Soundarrajan, Bharti Chogtu, Vybhava Krishna, Avinash Kamath G, Manisha Murugesan
Akathisia is a common movement disorder that occurs as a consequence of antipsychotic therapy. However, its occurrence secondary to risperidone withdrawal has been reported rarely. Reporting of such rare adverse event gains profound importance because...
Pages 80-83 Read Article
COMPLICATED CASE HISTORIES

An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome

Roland van Rensburg, Eric H. Decloedt
Neuroleptic malignant syndrome is a rare, idiosyncratic emergency associated with exposure to dopamine antagonists, commonly antipsychotic drugs. The typical clinical picture consists of altered consciousness, muscular rigidity, fever, and autonomic instability. While the condition has...
Pages 84-91 Read Article
COMPLICATED CASE HISTORIES

Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study

Raul Felipe Palma-Álvarez, Elena Ros-Cucurull, Josep Antoni Ramos-Quiroga, Carlos Roncero, Lara Grau-López
Cocaine-induced psychotic disorder (CIPD) is one of the most serious consequences of cocaine use. Despite the high frequency of CIPD, specific treatment for CIPD has been scarcely researched. Although supportive measures are the first approach,...
Pages 92-97 Read Article